Crescent Capital BDC (CCAP) Stock Forecast, Price Target & Predictions
CCAP Stock Forecast
Crescent Capital BDC stock forecast is as follows: an average price target of $18.50 (represents a -1.44% downside from CCAP’s last price of $18.77) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
CCAP Price Target
The average price target for Crescent Capital BDC (CCAP) is $18.50 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $19.00 to $18.00. This represents a potential -1.44% downside from CCAP's last price of $18.77.
CCAP Analyst Ratings
According to 3 Wall Street analysts, Crescent Capital BDC's rating consensus is 'Buy'. The analyst rating breakdown for CCAP stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Crescent Capital BDC Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 13, 2024 | Finian O'Shea | Wells Fargo | $18.00 | $18.19 | -1.04% | -4.10% |
| May 10, 2024 | Robert Dodd | Raymond James | $19.00 | $18.18 | 4.48% | 1.23% |
| Apr 25, 2022 | - | Wells Fargo | $18.50 | $17.80 | 3.91% | -1.44% |
The latest Crescent Capital BDC stock forecast, released on May 13, 2024 by Finian O'Shea from Wells Fargo, set a price target of $18.00, which represents a -1.04% decrease from the stock price at the time of the forecast ($18.19), and a -4.10% decrease from CCAP last price ($18.77).
Crescent Capital BDC Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $18.50 |
| Last Closing Price | $18.77 | $18.77 | $18.77 |
| Upside/Downside | -100.00% | -100.00% | -1.44% |
In the current month, the average price target of Crescent Capital BDC stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Crescent Capital BDC's last price of $18.77. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 13, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
| May 10, 2024 | Raymond James | Outperform | Outperform | Hold |
| Nov 13, 2023 | Wells Fargo | - | Equal-Weight | Downgrade |
| Aug 12, 2022 | Oppenheimer | - | Outperform | Upgrade |
Crescent Capital BDC's last stock rating was published by Wells Fargo on May 13, 2024. The company gave CCAP a "Equal-Weight" rating, the same as its previous rate.
Crescent Capital BDC Financial Forecast
Crescent Capital BDC Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $48.15M | - | $9.96M | $4.78M | $28.99M | - | $18.21M | $16.97M | $17.17M | $31.23M | $19.56M | $32.45M | $36.42M | $54.32M | $18.83M | $7.52M |
| Avg Forecast | $42.32M | $43.23M | $44.14M | $45.97M | $44.72M | $45.19M | $45.96M | $46.54M | $47.69M | $48.63M | $47.65M | $47.70M | $47.73M | $46.99M | $45.63M | $36.20M | $32.14M | $29.02M | $25.97M | $25.94M | $24.98M | $22.96M | $21.25M | $20.53M | $19.63M | $19.92M | $18.08M | $15.59M | $15.01M |
| High Forecast | $43.04M | $43.97M | $44.90M | $46.75M | $45.48M | $45.96M | $46.74M | $47.34M | $48.50M | $49.19M | $48.47M | $48.51M | $47.92M | $48.10M | $46.41M | $36.82M | $32.69M | $29.51M | $25.97M | $26.46M | $25.48M | $23.43M | $21.68M | $20.94M | $20.02M | $20.32M | $18.44M | $15.90M | $15.31M |
| Low Forecast | $41.60M | $42.49M | $43.39M | $45.18M | $43.96M | $44.42M | $45.17M | $45.75M | $46.87M | $48.06M | $46.84M | $46.88M | $47.53M | $45.96M | $44.85M | $35.58M | $31.59M | $28.52M | $25.97M | $25.26M | $24.32M | $22.36M | $20.69M | $19.99M | $19.11M | $19.40M | $17.60M | $15.18M | $14.61M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | - | 0.28% | 0.15% | 1.00% | - | 0.70% | 0.68% | 0.75% | 1.47% | 0.95% | 1.65% | 1.83% | 3.00% | 1.21% | 0.50% |
Crescent Capital BDC's average Quarter revenue forecast for Dec 23 based on 2 analysts is $47.73M, with a low forecast of $47.53M, and a high forecast of $47.92M. CCAP's average Quarter revenue forecast represents a -0.88% decrease compared to the company's last Quarter revenue of $48.15M (Sep 23).
Crescent Capital BDC EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $22.07M | - | $19.10M | $13.09M | $5.87M | - | $21.20M | $13.39M | $22.93M | $38.44M | $26.01M | $1.69M | $42.15M | $60.35M | $-70.41M | $12.88M |
| Avg Forecast | $41.55M | $42.45M | $43.34M | $45.14M | $43.91M | $44.37M | $45.13M | $45.70M | $46.82M | $47.75M | $46.79M | $33.09M | $46.87M | $46.14M | $44.81M | $26.16M | $31.56M | $21.62M | $25.50M | $20.68M | $13.07M | $19.66M | $20.87M | $20.16M | $1.66M | $19.56M | $17.75M | $-63.37M | $14.74M |
| High Forecast | $42.26M | $43.17M | $44.08M | $45.91M | $44.66M | $45.13M | $45.90M | $46.48M | $47.62M | $48.30M | $47.59M | $39.71M | $47.05M | $47.23M | $45.57M | $31.39M | $32.10M | $25.95M | $25.50M | $24.81M | $15.68M | $23.59M | $21.29M | $20.57M | $1.99M | $19.95M | $18.11M | $-50.70M | $15.04M |
| Low Forecast | $40.84M | $41.72M | $42.61M | $44.37M | $43.16M | $43.61M | $44.36M | $44.92M | $46.03M | $47.19M | $45.99M | $26.47M | $46.67M | $45.13M | $44.04M | $20.93M | $31.02M | $17.30M | $25.50M | $16.54M | $10.46M | $15.73M | $20.32M | $19.63M | $1.33M | $19.04M | $17.29M | $-76.05M | $14.35M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.48% | - | 0.73% | 0.41% | 0.27% | - | 1.03% | 1.02% | 1.17% | 1.84% | 1.29% | 1.02% | 2.15% | 3.40% | 1.11% | 0.87% |
2 analysts predict CCAP's average Quarter EBITDA for Dec 23 to be $46.87M, with a high of $47.05M and a low of $46.67M. This is 112.33% upper than Crescent Capital BDC's previous annual EBITDA (Sep 23) of $22.07M.
Crescent Capital BDC Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $22.62M | - | $7.78M | $2.60M | $-2.38M | - | $16.21M | $12.84M | $16.68M | $32.58M | $21.54M | $34.46M | $38.34M | $56.42M | $-74.55M | $9.18M |
| Avg Forecast | $18.16M | $18.53M | $18.90M | $20.01M | $19.06M | $19.39M | $19.66M | $19.85M | $20.76M | $21.20M | $21.52M | $25.31M | $21.13M | $20.67M | $20.28M | $20.00M | $16.18M | $15.73M | $15.33M | $15.81M | $12.53M | $14.30M | $36.93M | $21.99M | $33.71M | $42.33M | $52.48M | $-67.09M | $17.85M |
| High Forecast | $18.56M | $18.94M | $19.32M | $20.46M | $19.49M | $19.82M | $20.10M | $20.30M | $21.22M | $21.67M | $22.00M | $30.37M | $21.50M | $21.41M | $20.73M | $24.01M | $16.54M | $18.87M | $15.33M | $18.98M | $15.04M | $17.16M | $44.31M | $26.39M | $40.45M | $50.80M | $62.98M | $-53.67M | $18.31M |
| Low Forecast | $17.76M | $18.12M | $18.48M | $19.57M | $18.64M | $18.96M | $19.22M | $19.41M | $20.30M | $20.72M | $21.05M | $20.24M | $20.76M | $19.93M | $19.83M | $16.00M | $15.82M | $12.58M | $15.33M | $12.65M | $10.02M | $11.44M | $29.54M | $17.60M | $26.97M | $33.87M | $41.98M | $-80.51M | $17.23M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.09% | - | 0.39% | 0.16% | -0.15% | - | 1.03% | 1.02% | 1.17% | 0.88% | 0.98% | 1.02% | 0.91% | 1.08% | 1.11% | 0.51% |
Crescent Capital BDC's average Quarter net income forecast for Dec 23 is $21.13M, with a range of $20.76M to $21.50M. CCAP's average Quarter net income forecast represents a -6.59% decrease compared to the company's last Quarter net income of $22.62M (Sep 23).
Crescent Capital BDC SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.00M | - | $1.21M | $1.10M | $1.08M | - | $1.26M | $919.00K | $1.34M | $1.30M | $1.31M | $-2.36M | $-2.21M | $-2.40M | $-1.89M | $-1.50M |
| Avg Forecast | $4.80M | $4.91M | $5.01M | $5.22M | $5.08M | $5.13M | $5.22M | $5.28M | $5.41M | $5.52M | $5.41M | $1.97M | $5.42M | $5.33M | $5.18M | $1.56M | $3.65M | $1.26M | $2.95M | $1.23M | $897.12K | $1.15M | $1.48M | $1.34M | $-2.31M | $-2.44M | $-2.24M | $-1.70M | $1.70M |
| High Forecast | $4.89M | $4.99M | $5.10M | $5.31M | $5.16M | $5.22M | $5.31M | $5.37M | $5.51M | $5.58M | $5.50M | $2.37M | $5.44M | $5.46M | $5.27M | $1.87M | $3.71M | $1.52M | $2.95M | $1.48M | $1.08M | $1.38M | $1.77M | $1.60M | $-1.85M | $-1.96M | $-1.79M | $-1.36M | $1.74M |
| Low Forecast | $4.72M | $4.82M | $4.93M | $5.13M | $4.99M | $5.04M | $5.13M | $5.19M | $5.32M | $5.46M | $5.32M | $1.58M | $5.40M | $5.22M | $5.09M | $1.25M | $3.59M | $1.01M | $2.95M | $987.32K | $717.70K | $919.54K | $1.18M | $1.07M | $-2.77M | $-2.93M | $-2.68M | $-2.04M | $1.66M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.19% | - | 0.77% | 0.30% | 0.86% | - | 1.03% | 1.02% | 1.17% | 0.88% | 0.98% | 1.02% | 0.91% | 1.08% | 1.11% | -0.88% |
Crescent Capital BDC's average Quarter SG&A projection for Dec 23 is $5.42M, based on 2 Wall Street analysts, with a range of $5.40M to $5.44M. The forecast indicates a 441.25% rise compared to CCAP last annual SG&A of $1.00M (Sep 23).
Crescent Capital BDC EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.59 | - | $0.24 | $1.69 | $-0.08 | - | $0.52 | $0.46 | $0.59 | $1.16 | $0.76 | $1.22 | $1.36 | $2.00 | $-2.84 | $0.35 |
| Avg Forecast | $0.49 | $0.50 | $0.51 | $0.54 | $0.51 | $0.52 | $0.53 | $0.54 | $0.56 | $0.57 | $0.58 | $0.58 | $0.57 | $0.56 | $0.55 | $0.46 | $0.44 | $0.43 | $0.41 | $0.41 | $0.41 | $0.41 | $0.45 | $0.47 | $0.46 | $0.48 | $0.43 | $0.40 | $0.48 |
| High Forecast | $0.50 | $0.51 | $0.52 | $0.55 | $0.53 | $0.53 | $0.54 | $0.55 | $0.57 | $0.58 | $0.59 | $0.59 | $0.58 | $0.58 | $0.56 | $0.47 | $0.45 | $0.44 | $0.41 | $0.42 | $0.42 | $0.43 | $0.46 | $0.48 | $0.47 | $0.49 | $0.44 | $0.41 | $0.49 |
| Low Forecast | $0.48 | $0.49 | $0.50 | $0.53 | $0.50 | $0.51 | $0.52 | $0.52 | $0.55 | $0.56 | $0.57 | $0.57 | $0.56 | $0.54 | $0.53 | $0.45 | $0.43 | $0.42 | $0.41 | $0.40 | $0.40 | $0.40 | $0.43 | $0.45 | $0.44 | $0.46 | $0.42 | $0.39 | $0.46 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.06% | - | 0.52% | 3.87% | -0.18% | - | 1.27% | 1.11% | 1.42% | 2.58% | 1.62% | 2.66% | 2.83% | 4.65% | -7.10% | 0.73% |
According to 2 Wall Street analysts, Crescent Capital BDC's projected average Quarter EPS for Dec 23 is $0.57, with a low estimate of $0.56 and a high estimate of $0.58. This represents a -3.37% decrease compared to CCAP previous annual EPS of $0.59 (Sep 23).
Crescent Capital BDC Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| PTMN | Portman Ridge Finance | $18.46 | $26.00 | 40.85% | Strong Buy |
| TPVG | TriplePoint Venture Growth BDC | $8.53 | $11.25 | 31.89% | Hold |
| GBDC | Golub Capital BDC | $14.86 | $17.50 | 17.77% | Buy |
| CCAP | Crescent Capital BDC | $18.71 | $18.50 | -1.12% | Buy |
| CGBD | Carlyle Secured Lending | $17.52 | $16.00 | -8.68% | Hold |
| TCPC | BlackRock TCP Capital | $10.58 | $8.00 | -24.39% | Hold |
CCAP Forecast FAQ
Is Crescent Capital BDC a good buy?
Yes, according to 3 Wall Street analysts, Crescent Capital BDC (CCAP) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 66.67% of CCAP's total ratings.
What is CCAP's price target?
Crescent Capital BDC (CCAP) average price target is $18.5 with a range of $18 to $19, implying a -1.44% from its last price of $18.77. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Crescent Capital BDC stock go up soon?
According to Wall Street analysts' prediction for CCAP stock, the company can go down by -1.44% (from the last price of $18.77 to the average price target of $18.5), up by 1.23% based on the highest stock price target, and down by -4.10% based on the lowest stock price target.
Can Crescent Capital BDC stock reach $30?
CCAP's average twelve months analyst stock price target of $18.5 does not support the claim that Crescent Capital BDC can reach $30 in the near future.
What are Crescent Capital BDC's analysts' financial forecasts?
Crescent Capital BDC's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $182.41M (high $185.52M, low $179.29M), average EBITDA is $179.11M (high $182.17M, low $176.05M), average net income is $77.97M (high $79.7M, low $76.24M), average SG&A $20.71M (high $21.06M, low $20.35M), and average EPS is $2.1 (high $2.15, low $2.06). CCAP's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $175.66M (high $178.65M, low $172.66M), average EBITDA is $172.48M (high $175.43M, low $169.54M), average net income is $75.61M (high $77.28M, low $73.93M), average SG&A $19.94M (high $20.28M, low $19.6M), and average EPS is $2.04 (high $2.09, low $1.99).
Did the CCAP's actual financial results beat the analysts' financial forecasts?
Based on Crescent Capital BDC's last annual report (Dec 2022), the company's revenue was $20.22M, which missed the average analysts forecast of $113.07M by -82.11%. Apple's EBITDA was $45.44M, missing the average prediction of $99.36M by -54.27%. The company's net income was $15.54M, missing the average estimation of $63.06M by -75.35%. Apple's SG&A was $4.49M, missing the average forecast of $9.1M by -50.68%. Lastly, the company's EPS was $2.16, beating the average prediction of $1.69 by 27.53%. In terms of the last quarterly report (Sep 2023), Crescent Capital BDC's revenue was $48.15M, beating the average analysts' forecast of $46.99M by 2.48%. The company's EBITDA was $22.07M, missing the average prediction of $46.14M by -52.16%. Crescent Capital BDC's net income was $22.62M, beating the average estimation of $20.67M by 9.44%. The company's SG&A was $1M, missing the average forecast of $5.33M by -81.23%. Lastly, the company's EPS was $0.59, beating the average prediction of $0.558 by 5.79%